Cantor Fitzgerald raises its price target on Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY) from $32 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE